Gordana B. Attallah,Wei Chen,Zhaozhong J. Jia,Alfonso Pozzan,Luca F. Raveglia,Riccardo Zanaletti
申请号：
US15579142
公开号：
US20180305348A1
申请日:
2016.06.02
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Disclosed herein are reversible and irreversible inhibitors of Bruton's tyrosine kinase (Btk). Also disclosed are pharmaceutical compositions that include the compounds. Methods of using the Btk inhibitors are described, alone or in combination with other therapeutic agents, for the treatment of autoimmune diseases or conditions, heteroimmune diseases or conditions, cancer, including lymphoma, and inflammatory diseases or conditions.
